Sleep Apnea Devices Market Worth $12.9 billion by 2027 at a CAGR of 10.3% – Pre and Post COVID-19 Market Estimates by Meticulous Research®

The strong indirect economic impact of the undiagnosed sleep apnea in terms of workplace accidents, roadside accidents, lost productivity, and comorbid diseases & serious health problems and their rising awareness has created the traction in the need of sleep apnea diagnosis and therapy, thereby ultimately driving the demand for related medical devices. The factors such as large number of undiagnosed sleep apnea patients, increasing public and clinical awareness about sleep apnea with growing public & private sector initiatives, significant venture capital funding in the area of sleep apnea, growing usage of oral appliances, and technological advancement in devices are driving the growth of this market. In addition, rising healthcare expenditure and increase in the disposable income in emerging countries further supports the growth of this market.

Download Free Sample Report Now @

According to a new market research report titled “Sleep Apnea Devices Market by Type (Therapeutic Devices (CPAP, APAP, BPAP, ASV, Oral Appliances, Masks)), Diagnostic Devices (PSG, Oximeter, Home Sleep Testing Devices), End User (Hospitals & Sleep Labs, Home Care Settings/Individuals) – Global Forecast to 2027”, the sleep apnea devices market is expected to grow at a CAGR of 10.3% from 2020 to 2027 to reach $12.9 billion by 2027.

Impact of COVID-19 on Sleep Apnea Devices Market

The current worldwide severe outbreak of COVID-19 has created an unprecedented global demand for advanced healthcare infrastructure and medical devices including ventilators, patient monitors for the treatment of infected population. However, with the current drastically increasing pandemic COVID-19 crisis, the available ventilator capacity is not sufficient and the global healthcare industry is experiencing a severe shortage of the ventilators. Therefore, considering the shortage of ventilators and its surging demand across the globe, the key players offering ventilators have already doubled their production and some of the players have also planned to quadruple the production by the end of this year.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:

Geographically, North America region is estimated to command the largest share of the global sleep apnea devices market in 2020, owing to higher demand for sleep apnea devices due to the comparatively higher share of sleep apnea diagnosis in the region, higher adoption of advanced medical devices in the healthcare system, well established healthcare system with a wide network of suppliers & distributors. In addition, the rising initiatives by government & private players to increase the awareness among population, higher & rising healthcare expenditure, availability of the technologically upgraded products from the key players in the region, and increasing spending for product innovation are further expected to support the growth in this market during the forecast period. However, Asia-Pacific region is slated to register the fastest growth in the overall sleep apnea devices market during the forecast period, primarily due to the rising prevalence and large base of undiagnosed sleep disordered breathing (SDB) patients, rising focus of the key players to expand in emerging countries like China & India and other Southeast Asian countries through a number of strategic initiatives, and public & private sector initiatives on improving awareness about sleep disorders and related therapy.

Please visit:

Scope of the report                  

Sleep Apnea Devices Market by Type                         

  • Therapeutic devices
    • Positive Airway Pressure (PAP) Devices
      • Automatic Positive Airway Pressure Devices
      • Continuous Positive Airway Pressure Devices
      • Bilevel Positive Airway Pressure Devices
    • Masks
      • Full-Face Masks
      • Nasal Pillow Masks
      • Nasal Masks
    • Oral Appliances
      • Mandibular Advancement Devices
      • Tongue-Retaining Devices
    • Adaptive Servo-Ventilators
    • Oxygen Devices/ Oxygen concentrator
    • Accessories
  • Diagnostic devices
    • Polysomnography (PSG) Devices
      • Clinical Polysomnography Devices
      • Ambulatory Polysomnography Devices
    • Home sleep testing devices
    • Oximeters
      • Fingertip Oximeters
      • Hand-held Oximeters
      • Wrist-worn Oximeters
      • Table top Oximeters
    • Actigraphy Systems

Sleep Apnea Devices Market by End user

  • Hospitals & Sleep Laboratories
  • Home Care Settings/Individuals

Sleep Apnea Devices Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • RoE
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • RoAPAC
  • Latin America
  • Middle East and Africa

Check Discount:

Asia-Pacific: The fastest growing regional market

The North America is estimated to command the largest share of the overall sleep apnea market in 2020, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific region is expected to witness a rapid growth during the forecast period.

The key players operating in the global sleep apnea devices market are ResMed Inc. (U.S.), BMC Medical Co., Ltd. (China), Braebon Medical Corporation (Canada), Compumedics Limited (Australia), DeVilbiss Healthcare (U.S.), Fisher & Paykel Healthcare (New Zealand), Koninklijke Philips N.V. (Netherlands), Löwenstein Group (Germany), Oventus Medical (Australia), Panthera Dental (Canada), SomnoMed Limited (Australia), and Mitsui Chemicals, Inc. (WholeYou) (U.S.), among others.

Download Free Sample Report Now @

Related Reports:

1. Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User – Global Forecast to 2027

2. In-Vitro Toxicology/Toxicity Testing Market by Product and Service, Technology (Cell Culture, OMICS), Method (Cell-based Assays, In-Silico), End-point (ADME, Genotoxicity, Organ Toxicity, Dermal Toxicity), End-user, and Geography – Global Forecast to 2025

Meticulous Research®
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Visit Our Website: